External Expert Evaluator / 2019 — Present

Reviews and evaluates research project proposals.

Scientific Consultant / 2022 — Present

Reviews and writes research project proposals for researchers applying for US NIH and DOD funding

Consultant in Virology / 2020 — 2020

Researched and reviewed the scientific literature on SARS-CoV-2 virology to support decision-making and advised on the National Public Health control measures for COVID-19.

Consultant in Virology / 2019 — 2021

• Researched and reviewed the scientific literature on SARS-CoV-2 virology to support decision-making, and advised on strategic guidelines for controlling COVID-19. • Developed the outline of a program for managing hepatitis B among patient employees. • Managed the information outcome of the assessment of SafeCare Standards of Heineken health clinics in Africa and liaised with stakeholders for problem-solving.

Researcher / 2010 — 2017

• Researched molecular determinants of fitness in (re)emerging viruses, molecular epidemiology, and risk assessment. • Liaised with stakeholders across departments to strategically plan research and project management. • Designed research plans, wrote grant proposals, and secured European and National funding. • Wrote SOPs and guidelines for BSL2 and BSL3 biosafety and biosecurity; Evaluated compliance with regulatory standards. • Trained peer scientists in experimental procedures, biosafety and biosecurity, and data analysis software. • Wrote manuscripts, reports, and scientific communications. Collaborated in the peer review and content editing of grant proposals and manuscripts from peer scientists across research departments and institutions.

Assistant professor Public Health / 2005 — 2016

Coordinated, developed pedagogical content, and taught the course of Public Health to the Master's Degree in Pharmaceutical Sciences and Bachelor’s Degrees in Radiology, Clinical Analysis, and Pharmacy͘.

Consultant in Virology / May, 2008 — December, 2009

• Assessed capabilities and trained National Influenza Centers (NICs) in laboratory surveillance of zoonotic and pandemic influenza, biosafety and biosecurity, and compliance with regulatory standards. • Liaised with stakeholders, healthcare institutions, and the National Health Authorities and advised on measures to sustain the national laboratory surveillance of zoonotic, epidemic, and pandemic threats. • Assessed NICs’ readiness and priority needs in preparation for subsequent pandemic waves.

Researher / 2001 — 2009

• Researched genomic surveillance, molecular epidemiology, and risk assessment of (re)emerging viral threats. • Developed strategies for laboratory surveillance of emerging unknown viruses, zoonotic and pandemic influenza viruses, hemorrhagic fever, poxviruses, zoonotic coronaviruses, measles, and mumps. • Collaborated in writing National Contingency Plans to respond to emerging viral threats. • Collaborated in the strategic design of research projects and project management. • Collaborated in writing biosafety and biosecurity SOPs and guidelines for BSL2/BSL3 laboratories, compliant with regulatory standards. • Liaised with stakeholders, healthcare institutions, and national health authorities and collaborated in defining national strategies for the surveillance of emerging infections and vaccine-preventable diseases. • Developed pedagogical content and trained the Network of National Hospital Laboratories.